Who Paid My Doc
Acp-103-070
ClinicalTrials.gov NCT05555615
Research payments
$2,200,862
Through program year 2025, $2,200,862 in research payments was reported against Acp-103-070, across 346 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT05555615
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $452,798 | 67 |
| 2024 | Research | $1,048,859 | 160 |
| 2023 | Research | $626,056 | 114 |
| 2022 | Research | $73,148 | 5 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Isaac Melamed Centennial, CO Named on 29 payments
- Morteza Nadjafi Orlando, FL Named on 26 payments
- Mark Dibuono Staten Island, NY Named on 25 payments
- Raun Melmed Scottsdale, AZ Named on 23 payments
- James Knutson Kirkland, WA Named on 23 payments
- Elias Sarkis Gainesville, FL Named on 22 payments
- Elysa Marco San Francisco, CA Named on 21 payments
- Bradley Musser Richardson, TX Named on 20 payments
- Ann Childress Las Vegas, NV Named on 17 payments
- Riaz Baber Naperville, IL Named on 17 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.